bih.button.backtotop.text
BROWSE BY TEST NAME
#
%
1
2
3
5
8
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Z
Clear
 
Test Code (รหัสการทดสอบ):
090-71-5520

Order Name (ชื่อการทดสอบ):
INVITAE Multi-Cancer Panel (Diagnostic test) **

 
Specimen / Container (สิ่งส่งตรวจ/ภาชนะ):
Blood/ K3 EDTA (Lavender Top) 6 mL, 1 tube

Document Required:
Completed Requesition Form (Select Multi-Cancer Panel) LAB-REQ04-Rev01-0206_INVITAE-Diagnostics.pdf
& Completed Consent Form LAB-08170-Rev04-EN-Consent-for-Genomic-Medicine-Testing.pdf
 
Turnaround Time (ระยะเวลารอผล):
30 days
 
Useful For (ประโยชน์การทดสอบ):

This panel may be considered for individuals with:

  • a personal or family history presenting with multiple cancer types that could fit the features of more than one hereditary cancer syndrome
  • a clinical history indicative of a hereditary cancer syndrome but a limited pedigree due to small family size or adoption

There are also some common general features suggestive of a family with a hereditary cancer syndrome. These include:

  • cancer diagnosed at an unusually young age
  • different types of cancer that have occurred independently in the same person
  • cancer that has developed in both organs of a set of paired organs (e.g., both kidneys, both breasts)
  • several close blood relatives that have the same type of cancer
  • unusual cases of a specific cancer type (e.g., male breast cancer)
 
Methodology (วิธีการทดสอบ):
Next-generation sequencing (NGS)
 
AliasesName (ชื่อเรียกอื่นๆ) :
INVITAE 1 Panel Genetic Testing (Diagnostic test) 
 
 
 
Test Code (รหัสการทดสอบ):
090-71-5520

Order Name (ชื่อการทดสอบ):
INVITAE Multi-Cancer Panel (Diagnostic test) **

 
Patient Preparation (การเตรียมตัวผู้ป่วย):
Genetics Counseling
 
Collection Specimen Or Container (สิ่งส่งตรวจ/ภาชนะ):
Blood/ K3 EDTA (Lavender Top) 6 mL, 1 tube

Document Required:
Completed Requesition Form (Select Multi-Cancer Panel) LAB-REQ04-Rev01-0206_INVITAE-Diagnostics.pdf
& Completed Consent Form LAB-08170-Rev04-EN-Consent-for-Genomic-Medicine-Testing.pdf
 
Specimen Testing Type (สิ่งส่งตรวจที่ใช้ในการทดสอบ):
Blood/ K3 EDTA (Lavender Top) 6 mL, 1 tube
 
Sub Mission Container (ภาชนะส่งตรวจ):
Whole blood EDTA, minimum volume 6 mL
 
Rejection Criteria (เกณฑ์ปฏิเสธสิ่งส่งตรวจ):
  • Hemolyzed or clotted blood
  • Blood (or saliva) from patients who have had an allogeneic (non-self donor) bone marrow transplant
  • Blood (or saliva) from patients who have had an allogeneic (non-self donor) stem cell transplant
  • Blood (or saliva) from patients who had a blood transfusion less than two weeks prior to specimen collection
 
Specimen Stabillity (ความคงตัวของสิ่งส่งตรวจ):
Specimen Type Temperature Time
Whole blood EDTA Refrigerated, 2oC to 8oC 14 days
Saliva (2mL) in special collection kit * Ambient 30 days
* Optional, Nurse can request the special collection kit from Lab 13th Floor, Tel. 14160-2​
** Sending to USA
 
 
 
 
Test Code (รหัสการทดสอบ):
090-71-5520

Order Name (ชื่อการทดสอบ):
INVITAE Multi-Cancer Panel (Diagnostic test) **

 
Method detail (วิธีการทดสอบ):
Next-generation sequencing (NGS)
 
Schedule (ตารางการทดสอบ):
N/A **Sent out to INVITAE, USA
 
Turnaround Time (ระยะเวลารอผล):
30 days
 
Performing Location (หน่วยงานที่ทำการทดสอบ):
INVITAE, USA
Referral Lab Services, Laboratory Department 14160-2
 
 
 
Test Code (รหัสการทดสอบ):
090-71-5520

Order Name (ชื่อการทดสอบ):
INVITAE Multi-Cancer Panel (Diagnostic test) **

 
 
Clinical Information (ข้อมูลทางคลินิก):

The Invitae Multi-Cancer Panel analyzes genes associated with hereditary cancers across major organ systems, including:

  • breast and gynecologic (breast, ovarian, uterine)
  • gastrointestinal (colorectal, gastric, pancreatic)
  • endocrine (thyroid, paraganglioma/pheochromocytoma, parathyroid, pituitary)
  • genitourinary (renal/urinary tract, prostate)
  • skin (melanoma, basal cell carcinoma)
  • brain/nervous system
  • sarcoma
  • hematologic (myelodysplastic syndrome/leukemia)

The Invitae Multi-Cancer Panel is designed to maximize diagnostic yield for individuals with a personal or family history of mixed cancers affecting multiple organ systems.

Genetic testing of these genes may confirm a diagnosis and help guide treatment and management decisions. Identification of a disease-causing variant would also guide testing and diagnosis of at-risk relatives. This test is specifically designed for heritable germline mutations and is not appropriate for the detection of somatic mutations in tumor tissue.

PTEN: Deletion/duplication analysis covers the promoter region.

 
Reference Value (ค่าอ้างอิง):
An interpretive report will be provided.
 
Clinical Reference (เอกสารอ้างอิง):
www.invitae.com (Retrieved: 18 Mar 2021)